List of directors and their roles and functions
Filed with HKEX · Stock code 2696 · · 2 pages · English
Summary by 6ix AI
This filing is a list of directors and their roles for Shanghai Henlius Biotech, Inc.. It details the members of the board of directors, including their titles and functions. The document also outlines the composition of various board committees and their respective members.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Shanghai Henlius Biotech, Inc. on 6ix
Earlier from Shanghai Henlius Biotech
- (1) Changes in non-executive director and independent non-executive director (2) appointment of chairman of the board and changes in composition of the board committees
- Interim report 2026
- Voluntary announcement - collaboration and license agreement with amberstone for two T Cell Engager products
- Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation
- Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation, and Accelerating Progress Towards C-MNC
Later from Shanghai Henlius Biotech
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Continuing connected transaction - revision of annual cap for the collaboration arrangements under the HLX01 agreement
- (1) Continuing connected transaction revision of annual cap for the collaboration arrangements under the HLX01 agreement (2) proposed appointment of non-executive director and independent non-executive director and notice of extraordinary general meeting
- Notice of extraordinary general meeting
- Proxy form for the 2026 first extraordinary general meeting to be held on Monday, 23 November 2026 (or any adjournment thereof)
Follow Shanghai Henlius Biotech into a list and get an email when it puts out news.
Follow Shanghai Henlius Biotech